β受体阻断药用药趋势分析  

Analysis on usage of β-receptor blocking drugs

作　　者：匡玉霞[1] 

机构地区：[1]武汉亚洲心脏病医院药剂科,湖北武汉430022

出　　处：《药学实践杂志》2005年第5期282-284,共3页Journal of Pharmaceutical Practice

摘　　要：目的:了解β受体阻断药应用状况及变化趋势,为临床合理用药提供科学依据。方法:对武汉亚洲心脏病医院2003-2004年应用β受体阻断药的数据资料进行统计分析。结果:β受体阻断药的用药金额和用药频度逐年增加。结论:我院β受体阻断药用药合理,第二代β受体阻断药美托洛尔、阿替洛尔仍占主导地位。Objective：To investigate the status and tendency of β-receptor antagonists usage, and offer scientific basis for reasonable usage of the drugs ib clinic treatment. Methods：The data of β-receptor antagonists usage in Wuhan Asia Heart Hospital during 2003 to 2004 were collected and analyzed. Results：The expense and frequency of β-receptor antagonists usage increase year by year. Conclusion ：The usage of β-receptor antagonists is reasonable in our hospital. The second generation of β-receptor antagonists, such as metoprolol and atenolol, are donlinant in clinic use.

关 键 词：Β受体阻断剂 DDD 用药频度 

分 类 号：R972[医药卫生—药品]